Gangnam Severance Hospital
No hidden fees – just official clinic prices. Pay at the clinic for Pancreatic neuroendocrine tumors treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pancreatic neuroendocrine tumors treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pancreatic neuroendocrine tumors treatment journey.
Dr. Kim Jin is a colorectal surgeon at Korea University Anam Hospital in Seoul. He is the Vice President of the Korean Association of Robotic Surgeons. Dr. Kim represents South Korea on the board of the Asia Pacific Endo-Lap Surgery Group. He performs surgical demonstrations for medical faculties in Hong Kong and Singapore.
Top medical centers for pancreatic neuroendocrine tumor treatment in South Korea include Severance Hospital and Korea University Anam Hospital. These JCI-accredited facilities offer advanced pancreatic enucleation and multidisciplinary care. Most centers utilize robotic surgery and advanced imaging to ensure precise tumor removal and preservation of organ function.
Bookimed Expert Insight: Korea University Anam Hospital is a strategic choice for high-precision cases. They pioneered robotic surgery methods and emphasize bloodless procedures. This approach significantly reduces infection risks and shortens recovery time for pancreatic patients. Their volume of 1.3 million annual patients suggests deep experience in managing complex oncology cases.
Patient Consensus: Patients note it is vital to secure a pathology second opinion for Ki-67 grading. High-volume university hospitals in Seoul are preferred for their specialized multidisciplinary tumor boards.
Treatment for pancreatic neuroendocrine tumors in South Korea involves multidisciplinary care at JCI-accredited university hospitals. Options include da Vinci robotic surgery, peptide receptor radionuclide therapy (PRRT), and targeted drug treatments. Specialists focus on tumor grade and Ki-67 index to determine precise surgical or systemic protocols.
Bookimed Expert Insight: Korea University Anam Hospital utilizes bloodless surgery protocols to minimize infection risks during complex tumor resections. This is particularly valuable for pNET patients undergoing major pancreatic surgery. Their multidisciplinary teams integrate pathology and oncology to refine treatment plans after reviewing Ki-67 indexes.
Patient Consensus: Patients note that getting a detailed pathology report with the Ki-67 index is essential before surgery. Many emphasize that university hospitals coordinate specialist input faster than smaller clinics.
South Korean outcomes for pancreatic neuroendocrine tumors are excellent. Five-year survival rates exceed 80% for local cohorts. Large JCI-accredited tertiary centers achieve 10-year survival rates near 90% for small nonfunctioning tumors. These results match or exceed international standards found in Western Europe and North America.
Bookimed Expert Insight: Patient volume is a reliable indicator of outcomes in Seoul. Severance Hospital alone manages 1.6 million outpatients annually. Our data suggests this massive scale allows surgeons to specialize specifically in rare neuroendocrine variants rather than general pancreatic care. This volume-driven expertise likely contributes to Korea's high 93% recurrence-free survival rates.
Patient Consensus: Patients emphasize finding the highest-volume specialist rather than just a reputable hospital. They frequently praise the speed of Korean centers where workups and surgery scheduling happen much faster than in Western systems.
South Korean hospitals offer robot-assisted pancreatic surgery for pancreatic neuroendocrine tumors (pNETs). Specialized oncology centers in Seoul utilize the Da Vinci system and the domestic Revo-i platform. These systems allow for precise tumor removal, including procedures like pancreaticoduodenectomy and distal pancreatectomy.
Bookimed Expert Insight: Korea University Anam Hospital stands out for its high-volume robotic expertise. This clinic reports serving over 1,300,000 patients annually. Their surgeons specifically focus on robotic excellence in cancer surgery. This high volume often correlates with better technical precision in complex pancreatic resections.
Patient Consensus: Patients emphasize that the surgeon's specific experience with pancreatic cases is more important than the robot itself. They note that while robotic surgery leaves smaller scars, the recovery remains serious due to potential drainage requirements.
Management of advanced pancreatic neuroendocrine tumors in Korea involves a multidisciplinary approach. Specialized oncology centers utilize systemic therapies, such as everolimus and sunitinib, alongside targeted radionuclides. JCI-accredited facilities offer localized treatments like CyberKnife stereotactic radiosurgery and NanoKnife irreversible electroporation for complex metastases.
Bookimed Expert Insight: Korea is a high-volume hub. Centers like Severance Hospital serve 4 million patients yearly. This massive patient volume allows Korean specialists to manage rare cases including complex pNETs with high proficiency. Their expertise is consistently recognized in Newsweek's World's Best Hospitals rankings.
Patient Consensus: Patients emphasize the need for detailed pathology, specifically checking Ki-67 levels and receptor status. Confirming somatostatin-receptor positivity is a vital step before starting advanced radionuclide therapies.
Major Korean tertiary centers including Asan Medical Center, Seoul National University Hospital, and Samsung Medical Center provide Lutetium-177 DOTATATE PRRT for pancreatic neuroendocrine tumors. These JCI-accredited facilities utilize nuclear medicine departments to deliver targeted radiation. Treatment typically follows progression on somatostatin analogs.
Bookimed Expert Insight: Korea University Anam Hospital and Severance Hospital serve over 1,300,000 and 1,600,000 patients annually. This massive patient volume allows these centers to maintain dedicated multidisciplinary teams for rare conditions like pNETs. JCI-accredited hubs often centralize nuclear medicine, so treatment availability is highest in Seoul-based university hospitals.
Patient Consensus: Patients note it is important to confirm the nuclear medicine department actually performs PRRT dosing. Some centers provide the diagnostic DOTATATE scans but refer the actual treatment to larger national hubs.